LTUS (Lotus Pharma) going to Nasdaq Private placement deal (at prices above yesterday's close) includes Nasdaq listing in $5M deal. Based on 2008 projections, LTUS has a PE under 5 here. <a href="http://biz.yahoo.com/prnews/080226/cntu016.html?.v=44" target="_blank">http://biz.yahoo.com/prnews/080226/cntu016.html?.v=44</a>